 |
Page History
...
| Committee Member | Present | Absent |
|---|---|---|
| X | ||
| X | ||
| Pihl, Todd (NIH/NCI) [C] | X | |
| X | ||
| X | ||
| Gregory Tawa | X | |
| William Hendriks | X | |
| Matthew Breen | ||
| Roel Verhaak | X |
Goals
- Review, discuss, and prioritize ICDC study submission proposals
...
| Item | Who | Notes |
|---|---|---|
| Study Updates |
| |
| Test case for Osteosarcoma data from candidate publication list will be recommended to the SAC when clinical metadata is received | ||
| Data Transfer Agreement (DTA) - mechanism for reimbursing data submitters | Kuffel, Gina (NIH/NCI) [C] |
|
| Data Use Guidelines (DUG) and Intellectual Policy Statement | Kuffel, Gina (NIH/NCI) [C] |
|
Minutes (Not Verbatim)
PM - Plan for PanCan is to start with 1 of 8 studies that comprise the Zhao publication. University of Georgia is eliminating Google storage limits so Shaying needs a home for the 15 TB of data. FNL & NCI will provide recovery storage for the data and it will be stashed in a local EC2 instance. This will actually help us with data onboarding.
WK- We may not want to put the full licensing terms embedded into ICDC, it would be another thing to maintain.
EK- I will get back with Jason after I hear from ODS and to get more information about his reasoning for now accepting CC-BY. His revision on the IP statement has helped clarify.
